LAMIYA STARLING: Open Payments
NPI 1558741454 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59 |
| Octapharma USA, Inc. | 1 | $21 |
| ABIOMED | 1 | $21 |
Products named: FASENRA, JARDIANCE, BALFAXAR.
Industry payments across TX — which companies pay providers there.
